The global market for Infertility Treatment was valued at US$1.8 Billion in 2024 and is projected to reach US$2.8 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Infertility Treatment market.
Recent trends in infertility treatment highlight significant advancements in medical technology and increased accessibility to treatment options. Innovations in ART have markedly improved success rates, with notable developments in genetic screening, embryo culture techniques, and cryopreservation. Preimplantation genetic testing (PGT) allows for the selection of embryos free from genetic disorders, enhancing the likelihood of successful implantation and healthy pregnancies. Advances in cryopreservation have improved the viability of frozen eggs, sperm, and embryos, allowing for greater flexibility in family planning. Minimally invasive surgical techniques, such as laparoscopy and hysteroscopy, have also enhanced treatment outcomes by reducing recovery times and minimizing surgical risks. There is a growing trend towards holistic and integrative approaches in infertility treatment, incorporating complementary therapies such as acupuncture, nutrition counseling, and stress management programs. These holistic strategies aim to improve overall reproductive health and support the effectiveness of medical treatments. Additionally, the increasing availability of fertility preservation options, including egg and sperm freezing, reflects societal shifts toward later childbearing due to personal, professional, or medical reasons.
The growth in the infertility treatment market is driven by several factors. Technological advancements, particularly in ART and genetic testing, have significantly enhanced treatment efficacy and success rates, making these options more attractive and accessible to a wider audience. The increasing prevalence of infertility, influenced by factors such as delayed childbearing, lifestyle changes, and rising incidences of health issues like obesity, diabetes, and polycystic ovary syndrome (PCOS), has led to a higher demand for infertility treatments. Social and cultural shifts have also played a pivotal role; greater acceptance and awareness of infertility issues have reduced stigma and encouraged more individuals and couples to seek medical help. Legislative changes and the expansion of healthcare coverage and insurance for infertility treatments in various regions have made these services more financially accessible. Furthermore, the rise in disposable income globally, particularly in emerging markets, has led to the growth of fertility clinics and increased availability of advanced infertility treatments. These factors collectively contribute to the dynamic expansion of the infertility treatment market, fostering continuous innovation and making these services more widely available and effective.
Segments: Product (Equipment, Media & Consumables, Accessories); Procedure (Assisted Reproductive Technology (ART), Artificial Insemination, Fertility Surgery, Other Procedures); End-Use (Fertility Centers, Hospitals & Surgical Clinics, Other End-Uses).
Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Infertility Treatment Market - Key Trends & Drivers Summarized
Infertility treatment encompasses a diverse array of medical interventions designed to assist individuals and couples facing challenges in conceiving naturally. These treatments range from pharmacological approaches, such as medications to stimulate ovulation, to surgical procedures addressing anatomical abnormalities in the reproductive system. Assisted reproductive technologies (ART), including in vitro fertilization (IVF), intrauterine insemination (IUI), and intracytoplasmic sperm injection (ICSI), are at the forefront of infertility treatment, offering advanced solutions for complex infertility issues. Infertility can stem from various causes affecting either or both partners, such as hormonal imbalances, genetic disorders, structural issues in the reproductive organs, and lifestyle factors like stress and diet. The process of undergoing infertility treatment often involves comprehensive testing to diagnose the underlying issues, followed by a tailored treatment plan and continuous monitoring to maximize the chances of a successful pregnancy. Additionally, emotional and psychological support is a crucial component, as the journey can be emotionally taxing and stressful for those involved.Recent trends in infertility treatment highlight significant advancements in medical technology and increased accessibility to treatment options. Innovations in ART have markedly improved success rates, with notable developments in genetic screening, embryo culture techniques, and cryopreservation. Preimplantation genetic testing (PGT) allows for the selection of embryos free from genetic disorders, enhancing the likelihood of successful implantation and healthy pregnancies. Advances in cryopreservation have improved the viability of frozen eggs, sperm, and embryos, allowing for greater flexibility in family planning. Minimally invasive surgical techniques, such as laparoscopy and hysteroscopy, have also enhanced treatment outcomes by reducing recovery times and minimizing surgical risks. There is a growing trend towards holistic and integrative approaches in infertility treatment, incorporating complementary therapies such as acupuncture, nutrition counseling, and stress management programs. These holistic strategies aim to improve overall reproductive health and support the effectiveness of medical treatments. Additionally, the increasing availability of fertility preservation options, including egg and sperm freezing, reflects societal shifts toward later childbearing due to personal, professional, or medical reasons.
The growth in the infertility treatment market is driven by several factors. Technological advancements, particularly in ART and genetic testing, have significantly enhanced treatment efficacy and success rates, making these options more attractive and accessible to a wider audience. The increasing prevalence of infertility, influenced by factors such as delayed childbearing, lifestyle changes, and rising incidences of health issues like obesity, diabetes, and polycystic ovary syndrome (PCOS), has led to a higher demand for infertility treatments. Social and cultural shifts have also played a pivotal role; greater acceptance and awareness of infertility issues have reduced stigma and encouraged more individuals and couples to seek medical help. Legislative changes and the expansion of healthcare coverage and insurance for infertility treatments in various regions have made these services more financially accessible. Furthermore, the rise in disposable income globally, particularly in emerging markets, has led to the growth of fertility clinics and increased availability of advanced infertility treatments. These factors collectively contribute to the dynamic expansion of the infertility treatment market, fostering continuous innovation and making these services more widely available and effective.
Report Scope
The report analyzes the Infertility Treatment market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.Segments: Product (Equipment, Media & Consumables, Accessories); Procedure (Assisted Reproductive Technology (ART), Artificial Insemination, Fertility Surgery, Other Procedures); End-Use (Fertility Centers, Hospitals & Surgical Clinics, Other End-Uses).
Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Equipment segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 7.5%. The Media & Consumables segment is also set to grow at 8.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $410.8 Million in 2024, and China, forecasted to grow at an impressive 9.0% CAGR to reach $647.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Infertility Treatment Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Infertility Treatment Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Infertility Treatment Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as FUJIFILM Holdings Corporation, Cook Group, Inc., EMD Serono, Inc., Ferring International Center SA, Fertipro NV and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 67 companies featured in this Infertility Treatment market report include:
- FUJIFILM Holdings Corporation
- Cook Group, Inc.
- EMD Serono, Inc.
- Ferring International Center SA
- Fertipro NV
- FUJIFILM Irvine Scientific
- Esco Micro Pte., Ltd.
- Gynotec B.V.
- Fertility Focus Ltd
- Genea Limited
- European Sperm Bank ApS
- INVO Bioscience
- Hi-Tech Solutions
- Gema sro
- Assisted Reproductive Technology Information System
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- FUJIFILM Holdings Corporation
- Cook Group, Inc.
- EMD Serono, Inc.
- Ferring International Center SA
- Fertipro NV
- FUJIFILM Irvine Scientific
- Esco Micro Pte., Ltd.
- Gynotec B.V.
- Fertility Focus Ltd
- Genea Limited
- European Sperm Bank ApS
- INVO Bioscience
- Hi-Tech Solutions
- Gema sro
- Assisted Reproductive Technology Information System
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 505 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1.8 Billion |
| Forecasted Market Value ( USD | $ 2.8 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
